Macro challenges are prompting different value-creation priorities to come to the fore, but the underlying fundamentals of the asset class remain intact.
PE-backed healthcare businesses can help improve patient access and outcomes, but thorough due diligence, support and oversight are needed to ensure progress is made on ESG.
Since the GFC, the industry has found itself the subject of increasing regulatory scrutiny, which has in turn helped shape the story of the asset class.